Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.

MLA

Asín-Prieto, Eduardo, et al. “Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Application to Pharmacokinetic/Pharmacodynamic Analysis.” The Journal of Antimicrobial Chemotherapy, vol. 69, no. 1, Jan. 2014, pp. 180–89. EBSCOhost, https://doi.org/10.1093/jac/dkt304.

APA

Asín-Prieto, E., Rodríguez-Gascón, A., Trocóniz, I. F., Soraluce, A., Maynar, J., Sánchez-Izquierdo, J. Á., & Isla, A. (2014). Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis. The Journal of Antimicrobial Chemotherapy, 69(1), 180–189. https://doi.org/10.1093/jac/dkt304

Chicago

Asín-Prieto, Eduardo, Alicia Rodríguez-Gascón, Iñaki F Trocóniz, Amaia Soraluce, Javier Maynar, José Ángel Sánchez-Izquierdo, and Arantxazu Isla. 2014. “Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Application to Pharmacokinetic/Pharmacodynamic Analysis.” The Journal of Antimicrobial Chemotherapy 69 (1): 180–89. doi:10.1093/jac/dkt304.